UNIPHARMA ApS: Financial statements 2022
CVR: 78881917
UNIPHARMA ApS (CVR 78881917) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 0 and a net result of DKK -88 compared with DKK -5,190 the year before. Equity amounted to DKK 56,457. The solvency ratio was 31.3%.
- Revenue
- 0 kr.
- Gross Profit
- 0 kr.
- Profit/Loss
- -88 kr.
- Equity
- 56,457 kr.
- Total Assets
- 180,502 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 0 | 0 | -88 | 56 t. | - |
| 2021 | - | - | -5 t. | 57 t. | - |
| 2020 | -5 t. | -5 t. | -5 t. | 62 t. | - |
| 2019 | -5 t. | -5 t. | -5 t. | 67 t. | - |
| 2018 | -10 t. | -10 t. | -10 t. | 72 t. | - |
Keep an eye on UNIPHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
UNIPHARMA ApS has published its annual report for 2021. The net result was DKK -5,190.
About UNIPHARMA ApS
UNIPHARMA ApS was a Danish company of the type Anpartsselskab based in København K, founded in 1985. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company is owned by Ebba Dorrit Reumert and Ebba Dorrit Reumert. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity amounted to DKK -124,033.
